Ayala Pharmaceuticals, Inc. (ADXS)

Ayala Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Sep 25, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	1	8	-
Enterprise Value	4	7	-
Last Close Price	0.02	0.67	-
PE Ratio	-	-0.08	-
PS Ratio	9.73	610.40	-
PB Ratio	-0.32	-0.32	-
P/FCF Ratio	-0.27	-0.27	-
P/OCF Ratio	-0.27	-0.27	-
EV/Sales Ratio	559.86	559.86	-
EV/EBITDA Ratio	-0.21	-0.21	-
EV/EBIT Ratio	-0.21	-0.21	-
EV/FCF Ratio	-0.25	-0.25	-
Debt / Equity Ratio	-0.34	-0.34	-1.59
Debt / FCF Ratio	-0.28	-0.28	-0.05
Asset Turnover	0.00	0.00	-
Quick Ratio	0.20	0.20	0.43
Current Ratio	0.30	0.30	0.51
Return on Assets (ROA)	-181.05%	-181.05%	-
Earnings Yield	-38031.55%	-605.81%	-
FCF Yield	-371.57%	-371.57%	-
Buyback Yield / Dilution	-107.90%	-
Total Shareholder Return	-107.90%	-

Source: S&P Capital IQ. Standard template. Financial Sources.